Nachrichten zur Illumina Inc. Aktie

This Gene Sequencing Company Is A Better Pick Over Walgreens Stock

We think that Illumina stock (NASDAQ: ILMN) currently is a better pick compared to the Walgreens stock (NYSE: WBA), despite…

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care

Study will evaluate whether blood-based testing can inform oncology providers about genetic variations within a patients cancer, which may influence…

Illumina Says Jury Awards Complete Genomics $334M in Patent Case

Illumina Says Jury Awards Complete Genomics $334M in Patent Case...…

UPDATE 1-Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case

...(Adds details) By Blake Brittain May 6 (Reuters) - A Delaware jury......…

Form 8-K ILLUMINA, INC. For: May 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina ordered to pay Chinese company $333 million in gene-sequencing patent case

...By Blake Brittain (Reuters) - A Delaware jury on Friday ordered......…

Illumina: Die durchwachsenen Q1-Zahlen und der schwache Ausblick - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Illumina-Aktienanalyse von "Der Aktionär": Jan Paul Fóri vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Illumina Inc. (ISIN:…

Illumina am Nasdaq 100-Ende – das ist der Grund

Die Papiere des Sequenzierungsspezialisten Illumina stehen am Freitag mächtig unter Druck: Zeitweise verzeichnet der Kurs den größten Rücksetzer seit Oktober…

Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Down

Illumina (ILMN) ended the first quarter with better-than-expected earnings and revenues on strength in Core Illumina and the GRAIL businesses…

Cancer Testing Drives Gene-Sequencing Sales at Illumina

The company reaffirmed that it wants to increase sales in blood-based cancer screening and new drug discovery....…

Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance

Illumina (ILMN) Q1 Earnings and Revenues Beat Estimates

Illumina (ILMN) delivered earnings and revenue surprises of 22.99% and 0.79%, respectively, for the quarter ended March 2022. Do the…

Illumina quarterly net income falls 41% due to GRAIL operating loss

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Inc. Q1 Profit Decreases, but beats estimates

SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) revealed earnings for first quarter that decreased from the same period last year…

Illumina Non-GAAP EPS of $1.07 beats by $0.18, revenue of $1.22B in-line

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina and Deerfield Management partner to accelerate drug development

First-of-its-kind partnership will identify drug targets and accelerate novel therapy development using genomics and artificial intelligence SAN DIEGO, May 5,…

Thinking about trading options or stock in Illumina, Progressive, Apple, Wayfair, or Marathon Petroleum?

NEW YORK, May 3, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ILMN, PGR, AAPL, W, and MPC. Click…

Insiderhandel: SVP & General Counsel verkauft Aktien von Illumina im Wert von 110.448$

Dadswell, Charles - Vorstand - Tag der Transaktion: 2022-04-28...…

Global Liquid Biopsy Markets Report 2022-2027 Featuring Thermo Fisher Scientific, Guardant Health, EXACT Sciences Corp, Illumina, Bio - Rad Laboratories, Biocept, NeoGenomics, & Qiagen NV

DUBLIN, April 29, 2022 /PRNewswire/ -- The "Global Liquid Biopsy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of…

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, April 28, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at…

Illumina, German hospital team up for genome sequencing to test genetic disease in ill children

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina unterstützt führendes deutsches Krankenhaus bei der Beschleunigung der Diagnose von genetischen Krankheiten bei schwerkranken Kindern

Illumina, Inc.: San Diego (ots/PRNewswire) - Eine Studie der Medizinischen Hochschule Hannover wird die Verwendung der Gesamtgenomsequenzierung bewerten, um die…

Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

Hannover Medical School study will evaluate the use of whole-genome sequencing to show positive impact of earlier diagnosis and treatment…

Illumina unterstützt führendes deutsches Krankenhaus bei der Beschleunigung der Diagnose von genetischen Krankheiten bei schwerkranken Kindern

Eine Studie der Medizinischen Hochschule Hannover wird die Verwendung der Gesamtgenomsequenzierung bewerten, um die positiven Auswirkungen einer früheren Diagnose und…

Global Home DNA Test Kit Market Report 2022-2028 Featuring 23andMe, Ancestry, Color Genomics, EasyDNA, Gene by Gene, Illumina, LivingDNA, Mapmygenome, MyHeritageDNA, SelfDecode, Veritas Genetics

DUBLIN, April 22, 2022 /PRNewswire/ -- The "Home DNA Test Kit Market Opportunity Forecast 2028" report has been added to…

James Anderson on Tesla, Illumina, Moderna, and Other Companies That Matter

Anderson, a partner at Baillie Gifford, is one of the preeminent growth-stock investors of his time. As he prepares to…

World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says

World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says...…

Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022

SAN DIEGO, April 14, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it will issue results for the…

Illumina (ILMN) Hurt by Rising Costs, Tough Competition

Regulatory complications are raising the legal expenses for Illumina (ILMN), thereby building pressure on the bottom line....…

Illumina (ILMN) Launches Genomic Solution Hub in Brazil

Illuminas (ILMN) customers and partners in Brazil currently span basic research, applied markets to clinical labs and healthcare institutions....…

John Frank Joins Illumina as Chief Public Affairs Officer

SAN DIEGO, April 11, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

Illumina: A Good Long-Term BioTech Investment

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chemistry X, Infinity, GRAIL: The New Illumina Is A Buy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: SVP Chief Medical Officer verkauft Aktien von Illumina im Wert von 715.700$

Febbo, Phillip G. - Vorstand - Tag der Transaktion: 2022-04-06...…

Illumina Releases Annual Corporate Social Responsibility Report

Report highlights contributions of genomics to advances in public health and overall health of our planet SAN DIEGO, April 7,…

Insiderhandel: SVP & General Counsel verkauft Aktien von Illumina im Wert von 126.161$

Dadswell, Charles - Vorstand - Tag der Transaktion: 2022-03-28...…

Analyst Ratings For Illumina

Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: Latest Ratings for ILMN DateFirmActionFromTo…

Illumina wins favorable ruling in patent dispute with BGI - Bloomberg

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insights on the Next-generation Sequencing Informatics Global Market to 2027 - Featuring Agilent Technologies, Illumina and Qiagen Among Others

DUBLIN, March 23, 2022 /PRNewswire/ -- The "Next-generation Sequencing Informatics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up…

Insights on the Pharmacogenomics Global Market to 2028 - Featuring Illumina, Agilent Technologies and Myriad Genetics Among Others

DUBLIN, March 21, 2022 /PRNewswire/ -- The "Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology,…

Illumina (ILMN) Debuts TSO Comprehensive Test in Europe

Illuminas (ILMN) novel CE-marked IVD kit for comprehensive genomic profiling will enable clinicians to match cancer patients with available therapies....…

Illumina stellt bahnbrechenden Test für umfassendes genomisches Profiling bei Krebs in Europa vor

Illumina, Inc.: San Diego, 16. März 2022 (ots/PRNewswire) - Der Einzel-In-vitro-Diagnostik-Test hilft, Entscheidungen zur Therapie gemäß klinischer Richtlinien zu treffen,…

Illumina stellt bahnbrechenden Test für umfassendes genomisches Profiling bei Krebs in Europa vor

Der Einzel-In-vitro-Diagnostik-Test hilft, Entscheidungen zur Therapie gemäß klinischer Richtlinien zu treffen, um so früh wie möglich im Krankheitsverlauf Präzisionsmedizin anzuwenden…

Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications

Illumina Accelerator portfolio grows to 68 startups 93% of graduate companies successfully secured additional capital SAN DIEGO, March 16, 2022…